Critical Illness After Hematopoietic Cell Transplantation

Starting soon

Conditions studied: Critical Illness, Ventilated Patients, Hematopoetic Stem Cell Transplantation, Transplant Complication

In brief

This is a prospective, multicenter observational trial for patients who develop critical illness after hematopoietic cell transplantation. Patients who are admitted to the intensive care unit after undergoing hematopoietic cell transplantation at the participating medical centers will be enrolled in this study. The clinical characteristics, laboratory profiles, managements, and clinical outcomes will be prospectively collected.

Key facts

Study ID
NCT07328724
Run by
Peking University People's Hospital
People needed
4000
Starts
2026-01-01
Expected to finish
2036-12-31
Last updated by the study team
2026-01-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.